Ryzodeg FlexTouch is a injection pharmaceutical product marketed by Novo Nordisk containing Insulin degludec + Insulin aspart; commonly 100 U/mL formulation, available for wholesale and bulk purchase on PharmaBag.
A combination insulin containing insulin degludec and insulin aspart. It provides long-acting and mealtime insulin action to help control blood sugar in diabetes.
| Product Name | Ryzodeg FlexTouch |
|---|---|
| Salt Composition | Insulin degludec + Insulin aspart; commonly 100 U/mL formulation |
| Manufacturer / Marketer | Novo Nordisk |
| Dosage Form | Injection |
| Product Category | Ethical |
Prices are wholesale rates offered by verified suppliers and exclude GST unless stated. Product information is provided for trade reference only and is not medical advice. Always verify the pack, batch and prescribing information before dispensing.
Ryzodeg FlexTouch contains Insulin degludec + Insulin aspart; commonly 100 U/mL formulation. Always confirm the composition and strength against the product pack and the prescribing information before dispensing.
Ryzodeg FlexTouch is marketed by Novo Nordisk. PharmaBag sources it through verified wholesale suppliers who hold valid drug licences.
Yes. PharmaBag is a B2B wholesale platform serving retail pharmacies, hospitals, clinics and distributors across India. Buyers complete a one-time verification with a drug licence and GST or PAN details, after which Ryzodeg FlexTouch can be ordered in bulk with a GST invoice and pan-India delivery.
Yes. Every order placed on PharmaBag, including Ryzodeg FlexTouch, is billed with a GST invoice from the supplying wholesaler at the applicable GST rate.
Other wholesale medicines with a comparable salt composition (Insulin degludec).